Your browser doesn't support javascript.
loading
Does Silybum marianum play a role in the treatment of chronic hepatitis C?
Torres, M; Rodríguez-Serrano, F; Rosario, D. J; Rodríguez-Perez, F; Toro, D. H.
Afiliação
  • Torres, M; s.af
  • Rodríguez-Serrano, F; s.af
  • Rosario, D. J; s.af
  • Rodríguez-Perez, F; s.af
  • Toro, D. H; s.af
P. R. health sci. j ; 23(2,supl): 69-74, Jun. 2004.
Artigo em Inglês | LILACS | ID: lil-500743
Biblioteca responsável: BR1.1
ABSTRACT

OBJECTIVES:

The recent boom in patient education on chronic hepatitis C has resulted in a worldwide increase in the diagnosis of this condition. Available treatment is expensive and associated with significant side effects; therefore, many patients seek for alternative medicine. Silybum marianum is a natural herb known to mankind for over 2,000 years that has been used as a liver-protecting agent due to its antioxidant properties. The objective of this study is to evaluate the safety profile and the effects of this herb, using a commercially available extract; in the liver chemistry and viral load of hepatitis C in chronically infected patients.

METHODS:

Patients aged 21-65 years old with a diagnosis of chronic hepatitis C who were not using antiviral therapy were asked to participate. Patients were randomized to treatment with S. marianum 160 mg orally three times a week for four weeks or to no-treatment (control). Blood tests for viral load and liver enzymes (ALT and AST) were done at randomization and at the end of treatment. Paired-t test was used to measure differences between baseline and week 4 values for ALT, AST and viral load. The percent change for ALT, AST and viral load of both groups was analyzed using the Mann Whitney statistical test.

RESULTS:

34 patients were enrolled. Men and women were equally distributed. Mean age was 50 years old. Mean baseline measurements of AST, ALT and viral load in the treatment group were 85 +/- 12.41 IU/ml, 120 +/- 20.57 IU/ml and 8.77 +/- 4.12 copies x 10(6)/ml while for the no-treatment group were 71 +/- 9.46 IU/ml, 97 +/- 15.35 IU/ ml and 1.8 +/- 0.62 copies x 10(6)/ml respectively. For treated subjects the mean values of AST, ALT and viral load demonstrated a decrease from baseline values, but this difference was not statistically significant. For control patients the values of ALT (p= .049), AST (p = .005) and viral load (p = .005) showed a statistically significant increase at week 4. Week 4 measurement chang...
Assuntos
Buscar no Google
Coleções: Bases de dados internacionais Contexto em Saúde: ODS3 - Saúde e Bem-Estar Problema de saúde: Meta 3.3: Acabar com as doenças tropicais negligenciadas e combater as doenças transmissíveis Base de dados: LILACS Assunto principal: Extratos Vegetais / Hepatite C Crônica / Silybum marianum / Fitoterapia Tipo de estudo: Ensaio clínico controlado Limite: Adulto / Feminino / Humanos / Masculino Idioma: Inglês Revista: P. R. health sci. j Assunto da revista: Medicina Ano de publicação: 2004 Tipo de documento: Artigo
Buscar no Google
Coleções: Bases de dados internacionais Contexto em Saúde: ODS3 - Saúde e Bem-Estar Problema de saúde: Meta 3.3: Acabar com as doenças tropicais negligenciadas e combater as doenças transmissíveis Base de dados: LILACS Assunto principal: Extratos Vegetais / Hepatite C Crônica / Silybum marianum / Fitoterapia Tipo de estudo: Ensaio clínico controlado Limite: Adulto / Feminino / Humanos / Masculino Idioma: Inglês Revista: P. R. health sci. j Assunto da revista: Medicina Ano de publicação: 2004 Tipo de documento: Artigo
...